Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Cizzle Biotech (CIZ) Share Price

Price 1.55p on 26-12-2025 at 05:12:23
Change 0.00p 0%
Buy 1.70p
Sell 1.40p
Last Trade: Sell 70,000.00 at 1.43p
Day's Volume: 0
Last Close: 1.55p
Open: 0.00p
ISIN: GB00BNG2VN02
Day's Range 0.00p - 0.00p
52wk Range: 1.25p - 2.65p
Market Capitalisation: £6.14m
VWAP: 0.00p
Shares in Issue: 396.39m

Cizzle Biotech (CIZ) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 70,000 1.43p Ordinary
12:23:16 - 24-Dec-25
Sell* 370 1.41p Ordinary
14:45:51 - 23-Dec-25
Sell* 14,539 1.41p Ordinary
14:36:19 - 23-Dec-25
Sell* 73,282 1.43p Ordinary
09:57:55 - 23-Dec-25
Buy* 59 1.70p Ordinary
09:26:45 - 23-Dec-25
Sell* 76,548 1.43p Ordinary
09:02:44 - 23-Dec-25
Buy* 29,792 1.63p Ordinary
14:36:05 - 22-Dec-25
Sell* 14,065 1.422p Ordinary
09:02:43 - 22-Dec-25
Buy* 448 1.70p Ordinary
08:34:05 - 19-Dec-25
Buy* 115 1.70p Ordinary
08:31:13 - 19-Dec-25
See more Cizzle Biotech trades

Cizzle Biotech (CIZ) Share Price History

Time period:
to
Date Open High Low Close Volume
26th Dec 2025 (Fri) 1.55 1.55 1.55 1.55 0
25th Dec 2025 (Thu) 1.55 1.55 1.55 1.55 0
24th Dec 2025 (Wed) 1.55 1.55 1.55 1.55 70,000
23rd Dec 2025 (Tue) 1.55 1.55 1.55 1.55 164,798
22nd Dec 2025 (Mon) 1.55 1.55 1.55 1.55 43,857
19th Dec 2025 (Fri) 1.55 1.55 1.55 1.55 563
18th Dec 2025 (Thu) 1.55 1.55 1.55 1.55 129,818
17th Dec 2025 (Wed) 1.55 1.55 1.55 1.55 147,944
16th Dec 2025 (Tue) 1.55 1.55 1.55 1.55 160,000
15th Dec 2025 (Mon) 1.55 1.55 1.55 1.55 241,441
12th Dec 2025 (Fri) 1.60 1.60 1.60 1.60 26,753
11th Dec 2025 (Thu) 1.60 1.60 1.60 1.60 179,485
10th Dec 2025 (Wed) 1.60 1.60 1.50 1.60 307,630
9th Dec 2025 (Tue) 1.60 1.60 1.60 1.60 237,187
8th Dec 2025 (Mon) 1.60 1.60 1.60 1.60 238,227
5th Dec 2025 (Fri) 1.60 1.60 1.60 1.60 6,513
4th Dec 2025 (Thu) 1.60 1.60 1.60 1.60 622,793
3rd Dec 2025 (Wed) 1.55 1.60 1.55 1.60 475,302
2nd Dec 2025 (Tue) 1.65 1.65 1.55 1.55 282,565
1st Dec 2025 (Mon) 1.65 1.65 1.65 1.65 100,719
28th Nov 2025 (Fri) 1.65 1.65 1.65 1.65 62,073
See more Cizzle Biotech price history

Cizzle Biotech (CIZ) Regulatory News

Date Source Headline
5th Nov 2025 7:01 am RNS £250,000 Convertible Loan Note Issue
5th Nov 2025 7:00 am RNS LOI with leading UK Clinical Diagnostic Group
27th Oct 2025 11:32 am RNS Change of Registered Office
30th Sep 2025 7:00 am RNS Interim Results
29th Sep 2025 7:00 am RNS Update on Clinical Laboratory Partnerships in USA
18th Aug 2025 7:00 am RNS Commercial Progress in USA
30th Jun 2025 1:45 pm RNS Result of AGM
6th Jun 2025 11:00 am RNS Notice of AGM
28th May 2025 7:00 am RNS Holding(s) in Company
20th May 2025 7:00 am RNS £150,000 Convertible Loan Note Issue
See more Cizzle Biotech regulatory news

Cizzle Biotech (CIZ) Share News

EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx

30th Sep 2025 13:11

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: Capital Metals loss widens; Aptamer's contract

18th Aug 2025 22:11

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

TRADING UPDATES: GetsBusy backs sales outlook; Cizzle raises funds

20th May 2025 21:45

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Cizzle Biotechnology appoints Founder Dawn Coverley as CSO

2nd Jan 2025 14:29

Cizzle Biotechnology Holdings PLC - London-based life sciences company engaged in developing a blood test for the early detection of the different forms of lung cancer - Appoints Founder & Non-Executive Director Dawn Coverley as chief scientific officer, effective immediately. Says the new role replaces her position as a NED and accelerates its global licensing and partnership strategy to bring its non-invasive, cost effective, CIZ1B biomarker lung cancer blood test to market in 2025. Read More

EARNINGS: Alliance Pharma swings to profit; DG Innovate loss widens

30th Sep 2024 18:37

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

See more Cizzle Biotech news
FTSE 100 Latest
Value9,870.68
Change-18.54

Login to your account

Forgot Password?

Not Registered